Placebo-controlled trial of bexarotene, a retinoid x receptor agonist, as maintenance therapy for patients treated with chemotherapy for advanced non-small-cell lung cancer.

Authors
Category Primary study
JournalClinical Lung Cancer
Year 2001
This article has no abstract
Epistemonikos ID: caa616a7daa9805f10a0aa17594a7c46959dc52a
First added on: Apr 03, 2025